HARVARD BIOSCIENCE, INC. Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- HARVARD BIOSCIENCE, INC. treasury stock, value, acquired, cost method for the quarter ending 2011-12-31 was $0.00, a 100.00% decline year-over-year.
- HARVARD BIOSCIENCE, INC. treasury stock, value, acquired, cost method for the quarter ending 2011-09-30 was $0.00.
- HARVARD BIOSCIENCE, INC. treasury stock, value, acquired, cost method for the quarter ending 2010-12-31 was $10.00M.
- HARVARD BIOSCIENCE, INC. treasury stock, value, acquired, cost method for the quarter ending 2010-09-30 was -$3.25M.
- HARVARD BIOSCIENCE, INC. treasury stock, value, acquired, cost method for fiscal 2012 was $0.00.
- HARVARD BIOSCIENCE, INC. treasury stock, value, acquired, cost method for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
- HARVARD BIOSCIENCE, INC. treasury stock, value, acquired, cost method for fiscal 2010 was $5.00M, a 107.99% increase from fiscal 2009.
- HARVARD BIOSCIENCE, INC. treasury stock, value, acquired, cost method for fiscal 2009 was $2.40M.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-03-18 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $0.00 10-K · filed 2014-03-14 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | |
| 2010-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $5.00M 10-K · filed 2013-03-18 |
| 2010-09-30 | -$3.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | |
| 2009-12-31 | $2.40M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |